M
Marilyn J. Hammer
Researcher at Harvard University
Publications - 159
Citations - 2217
Marilyn J. Hammer is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 19, co-authored 119 publications receiving 1335 citations. Previous affiliations of Marilyn J. Hammer include University of California, San Francisco & University of Pittsburgh.
Papers
More filters
Journal ArticleDOI
Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy
Christine Miaskowski,Bruce A. Cooper,Michelle E. Melisko,Lee-may Chen,Judy Mastick,Claudia West,Steven M. Paul,Laura B. Dunn,Brian L. Schmidt,Marilyn J. Hammer,Frances Cartwright,Fay Wright,Dale J. Langford,Kathryn A. Lee,Bradley E. Aouizerat +14 more
TL;DR: To identify subgroups of patients based on their distinct experiences with 25 commonly occurring symptoms and to identify demographic and clinical characteristics associated with subgroup membership, a sample of 582 oncology outpatients received CTX.
Journal ArticleDOI
Self-management for adult patients with cancer: an integrative review.
Marilyn J. Hammer,Elizabeth Ercolano,Fay Wright,Victoria Vaughan Dickson,Deborah Chyun,Gail D'Eramo Melkus +5 more
TL;DR: Current interventions that direct patients in self-care management of symptoms and associated challenges with cancer/survivorship are helpful, but incomplete.
Journal ArticleDOI
The Contribution of Malglycemia to Mortality among Allogeneic Hematopoietic Cell Transplant Recipients
Marilyn J. Hammer,Corey Casper,Corey Casper,Ted Gooley,Ted Gooley,Paul O'Donnell,Paul O'Donnell,Michael Boeckh,Michael Boeckh,Irl B. Hirsch +9 more
TL;DR: Retrospective data indicate that malglycemia is associated with mortality following HCT, and the applicability of these findings to other situations and whether correcting mal Glycemia in HCT can lead to reductions in mortality remain to be determined.
Journal ArticleDOI
Stress and Symptom Burden in Oncology Patients During the COVID-19 Pandemic.
Christine Miaskowski,Steven M. Paul,Karin E. Snowberg,Maura Abbott,Hala T. Borno,Susan Chang,Lee-may Chen,Bevin Cohen,Marilyn J. Hammer,Stacey A. Kenfield,Kord M. Kober,Jon D. Levine,Rachel Pozzar,Kim F. Rhoads,Erin L. Van Blarigan,Katherine Van Loon +15 more
TL;DR: Alarmingly high rates of stress and an extraordinarily high symptom burden among cancer patients are identified, exceeding those previously benchmarked in this population and on par with non-cancer patients with PTSD.
Journal ArticleDOI
Threats of Bots and Other Bad Actors to Data Quality Following Research Participant Recruitment Through Social Media: Cross-Sectional Questionnaire.
Rachel Pozzar,Marilyn J. Hammer,Meghan Underhill-Blazey,Meghan Underhill-Blazey,Alexi A. Wright,James A. Tulsky,Fangxin Hong,Daniel A. Gundersen,Donna L. Berry,Donna L. Berry +9 more
TL;DR: The goal of the research was to describe and explain threats to sample validity and data integrity following recruitment of health research participants through social media and summarize recommended strategies to mitigate these threats.